Literature DB >> 32058359

Can Directed Compliant Running Reduce the Magnitude of Variables Associated With the Development of Running Injuries?

Ciarán P Ó Catháin1, Chris Richter2, Kieran Moran3.   

Abstract

ABSTRACT: Ó Catháin, CP, Richter, C, and Moran, K. Can directed compliant running reduce the magnitude of variables associated with the development of running injuries? J Strength Cond Res 36(3): 772-780, 2022-Running is one of the most popular modes of activity worldwide and provides numerous health benefits. However, impact forces associated with the foot contacting the ground have been implicated in the development of running related injuries. As such, previous studies have used various methods to alter running to reduce the magnitude of these impact forces. However, it is unclear what kinematic changes facilitate this reduced loading or how loading further up the body changes. In this study, verbal direction was used to teach subjects to run with a more compliant running technique. Kinetic and kinematics characteristics of each subjects "normal" running technique and new "compliant technique" were measured in a fatigued and unfatigued state. Energy expenditure of each running style was also measured. Verbally directed compliant running significantly decreased (17%) vertical ground reaction force impact peaks, sacral (41%) and head (28%) impact accelerations, and increased energy expenditure (21%), in comparison with normal running. Findings suggest that verbally directed compliant running may reduce the magnitude of variables associated with the development of running injuries.
Copyright © 2020 National Strength and Conditioning Association.

Entities:  

Mesh:

Year:  2022        PMID: 32058359     DOI: 10.1519/JSC.0000000000003522

Source DB:  PubMed          Journal:  J Strength Cond Res        ISSN: 1064-8011            Impact factor:   4.415


  1 in total

1.  Comparison of impact accelerations between injury-resistant and recently injured recreational runners.

Authors:  Aoife Burke; Sarah Dillon; Siobhán O'Connor; Enda F Whyte; Shane Gore; Kieran A Moran
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.